The real question is: which approach works better
By activating two separate hormonal pathways simultaneously, Tirzepatide: Dramatically reduces appetite and food cravings Slows gastric emptying, helping you feel full longer Improves insulin sensitivity and blood sugar regulation Reduces inflammation and supports metabolic health Signals the brain's hunger and reward centers to decrease the drive to overeat In clinical trials (the SURMOUNT program), patients lost an average of 2022% of their body weight over 72 weeks, results that rival bariatric surgery, without going under the knife
Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, et al
Noticeably fitter after just a few weeks Reply 18 people found this helpful
Top 5 Providers at a Glance If you are in a rush, here are our top 5 recommendations based on value and patient outcomes